Skip to main content
. 2018 Oct 24;18(6):1–139.

Table 29:

Reference Case Analyses—Results

Strategy Average Total Cost, $ (95% Confidence Interval) Incremental Cost, $a Average Total Effect, QALYs (95% Confidence Interval) Incremental Effect, QALYsb ICER, $/QALY
Adults (Age 18–55 Years), Postlingual Severe to Profound Sensorineural Hearing Loss, Sequential BCI
UCI 65,961 (58,974–73,738) 23.28 (16.67–28.13)
BCI sequential 113,470 (98,345–127,795) 47,509 (35,067–54,831) 24.25 (18.12–28.55) 0.97 (−6.67 to 8.17) 48,978
Children, Prelingual Severe to Profound Sensorineural Hearing Loss, Simultaneous BCI
UCI 88,848 (80,810–97,999) 36.07 (31.48–39.88)
BCI simultaneous 156,319 (143,526–170,580) 67,471 (61,527–73,799) 38.53 (29.19–44.39) 2.46 (−7.50 to 9.91) 27,427
Children, Postlingual Severe to Profound Sensorineural Hearing Loss, Sequential BCI
UCI 86,376 (78,429–95,389) 34.61 (30.21–38.27)
BCI sequential 152,010 (137,794–167,120) 65,634 (58,531–72,511) 36.77 (28.49–42.09) 2.16 (−6.69 to 8.84) 30,386

Abbreviations: BCI, bilateral cochlear implant; ICER, incremental cost-effectiveness ratio; QALY quality-adjusted life-year; UCI, unilateral cochlear implant.

a

Incremental cost = average cost BCI – average cost UCI.

b

Incremental effect = average effect BCI – average effect UCI.